Matches in Wikidata for { <http://www.wikidata.org/entity/Q95381234> ?p ?o ?g. }
Showing items 1 to 32 of
32
with 100 items per page.
- Q95381234 description "article scientifique publié en 2014" @default.
- Q95381234 description "im Februar 2014 veröffentlichter wissenschaftlicher Artikel" @default.
- Q95381234 description "wetenschappelijk artikel" @default.
- Q95381234 description "наукова стаття, опублікована в лютому 2014" @default.
- Q95381234 name "Romidepsin is effective and well-tolerated in patients ≥60 years old with relapsed or refractory peripheral T-cell lymphoma (PTCL): analysis from phase 2 trials" @default.
- Q95381234 name "Romidepsin is effective and well-tolerated in patients ≥60 years old with relapsed or refractory peripheral T-cell lymphoma (PTCL): analysis from phase 2 trials" @default.
- Q95381234 type Item @default.
- Q95381234 label "Romidepsin is effective and well-tolerated in patients ≥60 years old with relapsed or refractory peripheral T-cell lymphoma (PTCL): analysis from phase 2 trials" @default.
- Q95381234 label "Romidepsin is effective and well-tolerated in patients ≥60 years old with relapsed or refractory peripheral T-cell lymphoma (PTCL): analysis from phase 2 trials" @default.
- Q95381234 prefLabel "Romidepsin is effective and well-tolerated in patients ≥60 years old with relapsed or refractory peripheral T-cell lymphoma (PTCL): analysis from phase 2 trials" @default.
- Q95381234 prefLabel "Romidepsin is effective and well-tolerated in patients ≥60 years old with relapsed or refractory peripheral T-cell lymphoma (PTCL): analysis from phase 2 trials" @default.
- Q95381234 P1433 Q95381234-A962AF2F-C2BE-4D93-9908-C8D46CF1572C @default.
- Q95381234 P1476 Q95381234-D27F0156-CFE9-4EFD-854C-E380CF634DB5 @default.
- Q95381234 P304 Q95381234-219A6825-BB6E-4160-B20C-2A2A9A9A7FD6 @default.
- Q95381234 P31 Q95381234-7A8F1A24-F47A-4848-A89F-982942F00FC3 @default.
- Q95381234 P433 Q95381234-6DE3ECE4-3317-403D-8EB5-16A778A3A99F @default.
- Q95381234 P478 Q95381234-300B8963-1F67-4A0A-B372-EC2FE60AE8B2 @default.
- Q95381234 P577 Q95381234-B36E89C2-879C-4627-B56A-3A9BAB0EFDD2 @default.
- Q95381234 P698 Q95381234-AA50064A-C929-4606-A456-5D57DDF46B0D @default.
- Q95381234 P921 Q95381234-3029D735-EA0D-4A73-A71F-DD0FDE3372A5 @default.
- Q95381234 P921 Q95381234-9B1F7EF8-D9AF-4E60-9D54-DAB77CA537FD @default.
- Q95381234 P698 24852793 @default.
- Q95381234 P1433 Q26867024 @default.
- Q95381234 P1476 "Romidepsin is effective and well-tolerated in patients ≥60 years old with relapsed or refractory peripheral T-cell lymphoma (PTCL): analysis from phase 2 trials" @default.
- Q95381234 P304 "17-18" @default.
- Q95381234 P31 Q13442814 @default.
- Q95381234 P433 "2 Suppl 5" @default.
- Q95381234 P478 "12" @default.
- Q95381234 P577 "2014-02-01T00:00:00Z" @default.
- Q95381234 P698 "24852793" @default.
- Q95381234 P921 Q42824440 @default.
- Q95381234 P921 Q7168693 @default.